Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

SEEL Seelos Therapeutics Inc

1,28

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Seelos Therapeutics (NASDAQ:SEEL)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Seelos Therapeutics Charts.

Seelos Therapeutics (NASDAQ:SEEL)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Seelos Therapeutics Charts.

News Seelos Therapeutics Inc

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Montag 25 November 2024 (4 Tage vor) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Freitag 22 November 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 22 November 2024 (7 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 15 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 7 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 26 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 26 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 25 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mittwoch 25 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 24 September 2024 (2 Monate vor) • Edgar (US Regulatory)

Biotech Soars On Material Transfer Agreement
Dienstag 24 September 2024 (2 Monate vor) • AllPennyStocks.com

Form 8-K - Current report
Dienstag 3 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Seelos Therapeutics Inc News-Artikel

Financial Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen